20Sep 2023
New KidneyIntelX Test Validated for Diabetic Kidney Disease Progression Risk

New KidneyIntelX Test Validated for Diabetic Kidney Disease Progression Risk

Researchers have developed and validated KidneyIntelX.dkd, an updated test, for stratifying diabetic kidney disease (DKD) patients' risk of progression from stages 1 to 3. In a study involving 573 DKD participants, 15.4% experienced progression to PDKF over a median of 3.7 years. A random forest model was trained using biomarkers and clinical variables. In separate cohorts of 657 BioMe participants and 1197 CANVAS participants, 11.7% and 7.5%, respectively, experienced PDKF. The test classified participants into low-, moderate-, and high-risk levels, with significant hazard ratios after adjusting for clinical risk factors. This development supports FDA regulatory approval for clinical adoption.

  • #endo-diabetology

Like

Save

Share